100 related articles for article (PubMed ID: 2462383)
1. High-dose inhaled albuterol in severe chronic airflow limitation.
Vathenen AS; Britton JR; Ebden P; Cookson JB; Wharrad HJ; Tattersfield AE
Am Rev Respir Dis; 1988 Oct; 138(4):850-5. PubMed ID: 2462383
[TBL] [Abstract][Full Text] [Related]
2. Tachyphylaxis to systemic but not to airway responses during prolonged therapy with high dose inhaled salbutamol in asthmatics.
Lipworth BJ; Struthers AD; McDevitt DG
Am Rev Respir Dis; 1989 Sep; 140(3):586-92. PubMed ID: 2782734
[TBL] [Abstract][Full Text] [Related]
3. Beta-adrenoceptor responses to high doses of inhaled salbutamol in patients with bronchial asthma.
Lipworth BJ; Clark RA; Dhillon DP; Brown RA; McDevitt DG
Br J Clin Pharmacol; 1988 Nov; 26(5):527-33. PubMed ID: 2849969
[TBL] [Abstract][Full Text] [Related]
4. A single-dose comparison of inhaled albuterol and two formulations of salmeterol on airway reactivity in asthmatic subjects.
Gongora HC; Wisniewski AF; Tattersfield AE
Am Rev Respir Dis; 1991 Sep; 144(3 Pt 1):626-9. PubMed ID: 1679981
[TBL] [Abstract][Full Text] [Related]
5. A study with cumulative doses of formoterol and salbutamol in children with asthma.
Foucard T; Lönnerholm G
Eur Respir J; 1991 Nov; 4(10):1174-7. PubMed ID: 1687130
[TBL] [Abstract][Full Text] [Related]
6. Tiotropium bromide, a new long-acting antimuscarinic bronchodilator: a pharmacodynamic study in patients with chronic obstructive pulmonary disease (COPD). Dutch Study Group.
Maesen FP; Smeets JJ; Sledsens TJ; Wald FD; Cornelissen PJ
Eur Respir J; 1995 Sep; 8(9):1506-13. PubMed ID: 8575576
[TBL] [Abstract][Full Text] [Related]
7. Comparison of tremor responses to orally administered albuterol and terbutaline.
Jenne JW; Valcarenghi G; Druz WS; Starkey PW; Yu C; Shaughnessy TK
Am Rev Respir Dis; 1986 Oct; 134(4):708-13. PubMed ID: 3767127
[TBL] [Abstract][Full Text] [Related]
8. Efficacy, tolerability, and effect on asthma-related quality of life of formoterol bid via multidose dry powder inhaler and albuterol QID via metered dose inhaler in patients with persistent asthma: a multicenter, randomized, double-blind, double-dummy, placebo-controlled, parallel-group study.
Busse W; Levine B; Andriano K; Lavecchia C; Yegen U
Clin Ther; 2004 Oct; 26(10):1587-98. PubMed ID: 15598475
[TBL] [Abstract][Full Text] [Related]
9. Pilot study of bronchodilator response to inhaled albuterol delivered by metered-dose inhaler and a novel dry powder inhaler.
Kemp JP; Hill MR; Vaughan LM; Meltzer EO; Welch MJ; Ostrom NK
Ann Allergy Asthma Immunol; 1997 Oct; 79(4):322-6. PubMed ID: 9357377
[TBL] [Abstract][Full Text] [Related]
10. Effect of high-dose salbutamol on cardiac rhythm in severe chronic airflow obstruction: a controlled study.
Hall IP; Woodhead MA; Johnston ID
Respiration; 1994; 61(4):214-8. PubMed ID: 7973107
[TBL] [Abstract][Full Text] [Related]
11. High dose salbutamol in chronic bronchitis: comparison of 400 micrograms, 1 mg, 1.6 mg, 2 mg and placebo delivered by Rotahaler.
Jenkins SC; Moxham J
Br J Dis Chest; 1987 Jul; 81(3):242-7. PubMed ID: 3311117
[TBL] [Abstract][Full Text] [Related]
12. Metered dose inhaler salbutamol treatment of asthma in the ED: comparison of two doses with plasma levels.
Rodrigo G; Rodrigo C
Am J Emerg Med; 1996 Mar; 14(2):144-50. PubMed ID: 8924135
[TBL] [Abstract][Full Text] [Related]
13. Dose-response study of inhaled salmeterol in asthmatic patients with 24-hour spirometry and Holter monitoring.
Kemp JP; Bierman CW; Cocchetto DM
Ann Allergy; 1993 Apr; 70(4):316-22. PubMed ID: 8466097
[TBL] [Abstract][Full Text] [Related]
14. Dose response to ipratropium as a nebulized solution in patients with chronic obstructive pulmonary disease. A three-center study.
Gross NJ; Petty TL; Friedman M; Skorodin MS; Silvers GW; Donohue JF
Am Rev Respir Dis; 1989 May; 139(5):1188-91. PubMed ID: 2523681
[TBL] [Abstract][Full Text] [Related]
15. First-line therapy for adult patients with acute asthma receiving a multiple-dose protocol of ipratropium bromide plus albuterol in the emergency department.
Rodrigo GJ; Rodrigo C
Am J Respir Crit Care Med; 2000 Jun; 161(6):1862-8. PubMed ID: 10852758
[TBL] [Abstract][Full Text] [Related]
16. Prevention of exercise-induced bronchospasm in pediatric asthma patients: a comparison of salmeterol powder with albuterol.
Blake K; Pearlman DS; Scott C; Wang Y; Stahl E; Arledge T
Ann Allergy Asthma Immunol; 1999 Feb; 82(2):205-11. PubMed ID: 10071526
[TBL] [Abstract][Full Text] [Related]
17. Dose-response study of inhaled salbutamol powder in chronic airflow obstruction.
Corris PA; Neville E; Nariman S; Gibson GJ
Thorax; 1983 Apr; 38(4):292-6. PubMed ID: 6867983
[TBL] [Abstract][Full Text] [Related]
18. The pulmonary and extra-pulmonary effects of high-dose formoterol in COPD: a comparison with salbutamol.
Goldkorn A; Diotto P; Burgess C; Weatherall M; Holt S; Beasley R; Siebers R
Respirology; 2004 Mar; 9(1):102-8. PubMed ID: 14982610
[TBL] [Abstract][Full Text] [Related]
19. Inhaled bronchodilators reduce dynamic hyperinflation during exercise in patients with chronic obstructive pulmonary disease.
Belman MJ; Botnick WC; Shin JW
Am J Respir Crit Care Med; 1996 Mar; 153(3):967-75. PubMed ID: 8630581
[TBL] [Abstract][Full Text] [Related]
20. Dose response to inhaled salbutamol in chronic obstructive airways disease.
Teale C; Morrison JF; Page RL; Pearson SB
Postgrad Med J; 1991 Aug; 67(790):754-6. PubMed ID: 1754527
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
